Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
11.3M
-
Shares change
-
-847K
-
Total reported value, excl. options
-
$19M
-
Value change
-
-$424K
-
Put/Call ratio
-
0.03
-
Number of buys
-
26
-
Number of sells
-
-21
-
Price
-
$1.68
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q4 2022
67 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q4 2022.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.3M shares
.
Largest 10 shareholders include Tieton Capital Management, LLC (2.75M shares), VANGUARD GROUP INC (2.61M shares), ICONIQ Capital, LLC (1.3M shares), BlackRock Inc. (984K shares), MILLENNIUM MANAGEMENT LLC (663K shares), RENAISSANCE TECHNOLOGIES LLC (571K shares), GEODE CAPITAL MANAGEMENT, LLC (559K shares), STATE STREET CORP (177K shares), D. E. Shaw & Co., Inc. (156K shares), and CITADEL ADVISORS LLC (150K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.